The method that allows the most absorption is the sublingual application of the oil (under the tongue). Take your drops in front of a mirror (to make sure you get the correct dose) place them under your tongue and keep them there for 2-3 minutes before swallowing the remaining oil with a drink. We recommend following it with breakfast or dinner to further increase absorption (and to get rid of the taste in the back of your throat). Combine it with other CBD products like hemp tea or an e-liquid for an even stronger effect.
CannabiGold’s unique selling point is not its oil, however, but its method of application. A common customer issue is droppers leaking because, when the highly viscous oil gets in the rim of a conventional dropper, it is not easy to close the bottle tightly anymore. By listening to their customers and conducting research and testing in their state-of-the-art facilities, the R&D team at CannabiGold developed a precise dropper technology that would allow 10g of CBD oil to be delivered in 400 micro drops, one at a time.
In fact, the U.S. Food and Drug Administration (FDA) approved Epidiolex (a drug made with a purified form of CBD oil) in June 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy in patients 2 years of age and older. These two epilepsy forms are known as Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex is the first FDA-approved drug that contains a purified drug substance derived from marijuana.
CBD shows promise in the treatment of anxiety disorders, according to a report published in the journal Neurotherapeutics in 2015. Looking at results from experimental research, clinical trials, and epidemiological studies, the report’s authors found evidence that CBD may help treat generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. However, the authors caution that human-based research on CBD and anxiety is fairly limited at this point.
A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
“In all of the tests, the isolated CBD was ineffective both before and after a certain dosage, while the effectiveness of the full-spectrum solution continued to increase as higher doses were administered. The results all indicate that CBD is only effective against swelling and pain at a certain dose, and that cannabis solutions containing a full range of cannabinoids will continue to provide corresponding effects as the dosage is increased.”
In fact, the U.S. Food and Drug Administration (FDA) approved Epidiolex (a drug made with a purified form of CBD oil) in June 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy in patients 2 years of age and older. These two epilepsy forms are known as Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex is the first FDA-approved drug that contains a purified drug substance derived from marijuana.
×